isabelobrien, Author at European Medical Journal - Page 20 of 65

Pfizer completes exit from Haleon

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.

5 minutes with... Prof Alexander Egeberg, LEO Pharma

Prof Alexander Egeberg, Vice President, Head of Global Medical Affairs, LEO Pharma, reveals how the company is tackling unmet needs in dermatology.

Sebastian Stintzing

Onc Now: Episode 13: Metastatic Colorectal Cancer Unravelled

Sebastian Stintzing, Head of Department of Medicine, Division of Hematology, Oncology, and Cancer Immunology, Charité – Universitäetsmedizin, Berlin, Germany, discusses the most impactful research into metastatic colorectal cancer.

DeepHealth’s Naiara Martínez Cabrera on AI's role in radiology

In this episode, uncover how AI is shaking up the radiology space with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth.

AstraZeneca buys EsoBiotec in $1bn cell therapy deal

AstraZeneca has announced a $1bn agreement to acquire EsoBiotec, a Belgian biotech firm pioneering in vivo cell therapies.

Woman's hand holding pill

Daily pill for endometriosis to be offered by NHS

The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.

Tackling bias, driving change: A roundtable for International Women’s Day

How can the pharmaceutical industry ‘Accelerate Action’ on gender parity this International Women’s Day? Find out now.

Xavier Leleu

Hema Now: Episode 12: Breaking Boundaries in Multiple Myeloma Research

Xavier Leleu, Head of the Department of Hematology at Centre Hospitalier Universitaire (CHU), Université de Poitiers, France

Cartoon brain on green background

Phase 2 trial begins for psychedelic-based depression treatment

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.

Hand with vaccine

UK Chikungunya vaccine approval in sight for Bavarian Nordic

The UK MHRA has validated Bavarian Nordics’ marketing authorisation application for its single-dose chikungunya vaccine.